Results 171 to 180 of about 2,071 (187)
Some of the next articles are maybe not open access.

Identification of CLK1 Inhibitors by a Fragment–linking Based Virtual Screening

Molecular Informatics, 2016
AbstractAlternative splicing plays an important role in the regulation of protein biosynthesis. CDC2‐like kinases (CLKs) phosphorylate splicing factors rendering them a potential target for treating diseases caused by splicing dysregulation. As selective and potent inhibitors of CLK1 are still lacking, a fragment‐linking based virtual screening ...
Walter   +8 more
openaire   +2 more sources

CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis

Cancer Research
Abstract Cdc2-like kinase 1 (CLK1) has dual-specificity kinase ability to phosphorylate tyrosine and serine/threonine protein residues. CLK1 regulates many physiologic processes and has been shown to contribute to multiple types of cancer.
Shuai Xue   +12 more
openaire   +2 more sources

Human CDC2-Like Kinase 1 (CLK1): A Novel Target for Alzheimer’s Disease

Current Drug Targets, 2014
The cdc2-like kinases (CLKs) are an evolutionarily conserved group of dual specificity kinases belonging to the CMGC (cyclin-dependent kinases (CDKs), mitogen-activated protein kinases (MAP kinases), glycogen synthase kinases (GSK) and CDK-like kinases). The CLK family consists of four isoforms namely CLK1, CLK2, CLK3 and CLK4.
Princi, Jain   +5 more
openaire   +2 more sources

Selective recognition memory impairment in mitochondrial hydroxylase Clk1 mutant mice, rescued by antipsychotics

open access: yesActa Pharmacologica Sinica
Mitochondria are not only the most important organelles in eukaryotic cells that participate in energy metabolism, signal transduction, cell apoptosis and other physiological processes, but also essential regulators of neurodevelopment, neuroplasticity, survival and adult neurogenesis.
John L Waddington   +2 more
exaly   +3 more sources

Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins

Journal of Medicinal Chemistry, 2017
In cancer cells, kinases of the Clk family control the supply of full-length, functional mRNAs coding for a variety of proteins essential to cell growth and survival. Thus, inhibition of Clks might become a novel anticancer strategy, leading to a selective depletion of cancer-relevant proteins after turnover.
Ahmed K. ElHady   +3 more
openaire   +2 more sources

Characterisation of the murine CLK1 dual-specificity kinase.

2009
Murine Clk1 (also known as Sty) was identified as a dual-specificity kinase capable of phosphorylating serine, threonine and tyrosine residues when expressed in bacteria. Expression of Clk1 is deveolpmentally regulated at the level of RNA expression. Embryonic cells express two mRNAs of similar size, whereas differentiated cells express two additional ...
openaire   +2 more sources

Clk1

AfCS-Nature Molecule Pages, 2005
Leonard Rabinow, Patricia Uguen
openaire   +1 more source

An overview of cdc2‐like kinase 1 (Clk1) inhibitors and their therapeutic indications

Medicinal Research Reviews, 2023
Ahmed K Elhady   +2 more
exaly  

Home - About - Disclaimer - Privacy